Effect of TTC-909 on cerebral infarction following permanent occlusion of the middle cerebral artery in stroke prone spontaneously hypertensive rats

Journal Pharmacological Sciences

Volumn 91, Issue 4, 2003, Pages 305-312

  Karasawa, Yasuko ^c   Komiyama, Hiroko ^c   Yoshida, Shigeru ^c   Hino, Noriko ^c   Katsuura, Yasuhiro ^b   Nakaike, Shiro ^c   Araki, Hiroaki ^a  

^a EHIME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b TEIJIN LTD   (Japan)

^c TAISHO PHARMACEUTICAL CO LTD   (Japan)

Author keywords

Focal cerebral ischemia; Middle cerebral artery occlusion; Prostacyclin; Stroke; Stroke prone spontaneously hypertensive rats

Indexed keywords

ISOCARBACYCLIN; ISOCARBACYCLIN METHYL ESTER; MICROSPHERE; OZAGREL; PROSTACYCLIN DERIVATIVE; THROMBOXANE SYNTHASE INHIBITOR; XAMBONE INJECTION;

ANESTHESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN BLOOD FLOW; BRAIN CORTEX; BRAIN INFARCTION; BRAIN PROTECTION; CONTROLLED STUDY; DISEASE COURSE; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; NERVE CELL LESION; NONHUMAN; RAT; SPONTANEOUSLY HYPERTENSIVE RAT; STAINING;

EID: 0038730880     PISSN: 13478613     EISSN: None     Source Type: Journal    
DOI: 10.1254/jphs.91.305     Document Type: Article

References (33)

1. Chen ST, Hsu CY, Hogan EL, Maricq H and Balentine JD: A model focal ischemic stroke in the rat: Reproducible extensive cortical infarction. Stroke 17, 738-743 (1986)
2. Brint S, Jacewicz M, Kiessling M, Tanabe J and Pulsinelli W: Focal brain ischemia in the rat: Methods for reproducible neocortical infarction using tandem occlusion of the distal middle cerebral and ipsilateral common carotid arteries. J Cereb Blood Flow Metab 8, 474-485 (1988)
3. Tamura A, Graham DI, McCulloch J and Teasdale GM: Focal ischaemia in the rat: I. Description of technique and early neuropathological consequences following middle cerebral artery occlusion. J Cereb Blood Flow Metab 1, 53-60 (1981)
4. Coyle P and Jokelainen PT: Differential outcome to middle cerebral artery occlusion in spontaneously hypertensive stroke-prone rats (SHRSP) and Wistar Kyoto (WKY) rats. Stroke 14, 605-611 (1983)
5. Coyle P and Heistad DD: Development of collaterals in the cerebral circulation. Blood Vessels 28, 183-198 (1991)
6. Okuyama S, Shimamura-Harada H, Karasawa Y, Kawashima K, Araki H, Kimura M, Otomo S and Aihara H: Protective effect of minaprine in infarction produced by occluding middle cerebral artery in stroke-prone spontaneously hypertensive rats. Gen Pharmacol 22, 143-150 (1991)
7. Vane JR and Bergstrom S: Prostacyclin. Ravan Press, New York, NY (1979)
8. Gryglewski RJ and Stoch G: Prostacyclin and Its stable analogue iloprost. Springer, Berlin (1987)
9. Gryglewski RJ, Nowak S, Kostka-Trabka E, Kusmiderski J, Dembinska-Kiec A, Bieron K, Basista M and Szczyk B: Treatment of ischemic stroke with prostacyclin. Stroke 14, 197-202 (1983)
10. Hsu CY, Faught RE Jr, Farlan AJ, Coull BM, Huang DC, Hogan EL, Linet OI and Yatsu FM: Intravenous prostacyclin in acute nonhemorrhagic stroke: A placebo controlled double blind trial. Stroke 18, 352-358 (1987)
11. Huczynski J, Kostka-Trabka E, Sotowska W, Bieron K, Grodzinska L, Dembinska-Kiec A, Pykosz-Mazur E, Peczak E and Gryglewski RJ: Double-blind controlled trial of the therapeutic effects of prostacyclin in patients with completed ischemic stroke. Stroke 16, 810-814 (1985)
12. Moncada S: Biology and therapeutic potential of prostacyclin. Stroke 14, 157-168 (1983)
13. Awad I, Little J, Lucas F, Skrinska V, Slugg R and Lesser RP: Treatment of acute focal cerebral ischemia with prostacyclin. Stroke 14, 203-209 (1983)
14. Sawada K, Aoki K, Katsuura Y, Tanabe H, Kiyoki M and Araki H: Vasorelaxant effect of isocarbacyclin methyl ester incorporated into lipid microspheres on isolated canine arteries. Arzneimittelforschung 45, 985-988 (1995)
15. Inoue K, Aoki Y, Hayashi M, Kitahara S, Tanabe H, Kiyoki M and Araki H: Ex vivo antiplatelet effects of isocarbacyclin methyl ester incorporated in lipid microspheres in rabbit. Arzneimittelforschung 45, 980-984 (1995)
16. Shima K, Umezawa H, Chigasaki H, Okuyama S and Araki H: Stable prostacyclin improves postischemic microcirculatory changes in hypertensive rats. Acta Neurochir 137, 89-95 (1995)
17. 2 synthase. J Pharm Soc Jpn 114, 911-933 (1994)
18. Takagaki Y, Itoh Y, Aoki Y, Ukai Y, Yoshikuni Y and Kimura K: Inhibition of ischemia-induced fodrin breakdown by a novel phenylpyrimidine derivative NS-7: An implication for its neuroprotective action in rats with middle cerebral artery occlusion. J Neurochem 68, 2507-2513 (1997)
19. 2 relaxation time, and cerebral blood flow and volume in the temporal evolution of cerebral infarction following permanent middle cerebral artery occlusion in rats. Exp Neurol 169, 56-63 (2001)
20. Mottet I, Demeure R, Rataud J, Lucas M, Wahl F, Watscotte V, Thiran JP, Goudemant JF, Maldague B, Maloteaux JM and Stutzmann JM: Effects of riluzole on the evolution of focal cerebral ischemia: A magnetic resonance imaging study. MAGMA 5, 185-191 (1997)
21. 2+ channel blocker NS-7. I. Effect on the cerebral infarction and edema at the acute stage of permanent middle cerebral artery occlusion in rats. Brain Res 890, 162-169 (2001)
22. Mary V, Wahl F, Uzan A and Stutzmann JM: Enoxaparin in experimental stroke: Neuroprotection and therapeutic window of opportunity. Stroke 32, 993-999 (2001)
23. Kohno Y, Minagawa T, Suwa T, Kondo S, Esumi Y, Sugai S, Mitsugi K, Shimazaki J and Watanabe I: Pharmacokinetics of an oil-in-water emulsion containing isocarbacyclin methyl ester, TTC-909 (3): Tissue distribution in rats after single intraveneous administration. Xenobio Metab Dispo 10, 332-343 (1995)
24. Yamashita K, Kataoka Y, N-Nakashima M, S-Yamashita Y, Tanabe H, Araki H, Niwa M and Taniyama K: Neuroprotective effect of TTC-909, an isocarbacyclin methyl ester incorporated in lipid microspheres, on hippocampal delayed neuronal death of stroke-prone spontaneously hypertensive rats. Jpn J Pharmacol 71, 351-355 (1996)
25. 2 analogue. J Pharm Pharmacol 48, 1016-1022 (1996)
26. Nitatori T, Karasawa Y, Araki H, Higuchi S, Kominami E and Uchiyama Y: Effects of TTC-909 on delayed neuronal death of CA1 pyramidal neurons following brief ischemia: An autoradiographic study. Abstract of 25th Annual Meeting Soc for Neurosci, Nov, San Diego, 91.11 (1995)
27. 2 analog, TEI-7165, on ischemic neuronal damage in gerbils. Brain Res 769, 321-328 (1997)
28. Takechi H, Matsumura K, Watanabe Y, Kato K, Novori R, Suzuki M and Watanabe Y: A novel subtype of the prostacyclin receptor expressed in the central nervous system. J Biol Chem 271, 5901-5906 (1996)
29. Araki H and Karasawa Y: Effect of TTC-909, an isocarbacyclin methyl ester (clinprost) incorporated into lipid microspheres, on neuronal damage induced by cerebral ischemia. In Calcium Ion Modulators - The New Wave of Psychotropic Drugs, Edited by Inoue K and Watanabe Y, pp 99-114, Harwood Academic Publishers, Amsterdam (1998)
30. 2 synthetase inhibitor, OKY-046 on cerebral ischemia in spontaneously hypertensive rats. Clin Rep 25, 201-211 (1991)
31. Naito J, Komatsu H, Ujiie A, Hamano S, Kubota T and Tsuboshima M: Effects of thromboxane synthase inhibitors on aggregation of rabbit platelets. Eur J Pharmacol 91, 41-48 (1983)
32. Nishiyama M, Amaki M, Arisaka T, Ujiie A, Okada K, Ochi K, Ishido M, Sakaguchi K, Miyamoto S and Inagawa T: Studies on the metabolic fate of sodium (E)-3-[p-(1H-imidazol-1-ylmethyl)-phenyl]-2-propenoate (OKY-046 Na). Iyakuhin Kenkyu 17, 835-858 (1986) (in Japanese)
33. Paxinos G and Watson C: The Rat Brain in Stereotaxic Coordinates (Compact Third Edition). Academic Press, New York (1997)